MDK and breast carcinoma: A MDK-PI3K/AKT axis for modulating stem cells was also identified in breast cancer [34], and activation of Hippo/YAP levels via suppression of YAP/TAZ levels has also been implicated in MDK-mediated enhancement of cancer stem cell activity in vitro and in vivo [35].